V体育平台登录 - Surgical staging identified false HPV-negative cases in a large series of invasive cervical cancers
- PMID: 29179875
- PMCID: PMC5883200 (V体育2025版)
- DOI: 10.1016/j.pvr.2017.10.003 (VSports最新版本)
Surgical staging identified false HPV-negative cases in a large series of invasive cervical cancers
Abstract
Objective: We examined a large series of biopsy-proven invasive cervical cancers with surgical staging and HPV re-testing to estimate the relevance of HPV-negative cervical cancers in a Caucasian population VSports手机版. .
Methods: We prospectively collected smears from 371 patients with a biopsy-proven diagnosis of cervical cancer for HC2 testing of high-risk HPV (HR-HPV). In HC2-negative cases, smears and paraffin embedded tissue blocks underwent additional HPV genotyping V体育安卓版. .
Results: HC2 tests showed 31/371 cases (8. 8%) had negative findings. Surgical staging showed that 21/31 HC2-negative cases (68%) were not cervical cancer V体育ios版. Overall, 340/350 cases of primary cervical cancer confirmed by surgical staging tested HC2 positive (97. 2%). Non-high-risk HPV subtypes were detected in five cases (one HPV-53, one HPV-70, and three HPV-73) and high-risk subtypes in four patients with HC2-negative cervical cancer (two HPV 16 and two HPV-18). The remaining case, a primary undifferentiated carcinoma of the uterine cervix, tested negative for HPV-DNA with all tests. .
Conclusions: The main explanation for HPV-negative cervical cancer was a false diagnosis, followed by cancers associated with non-HR-HPV types, and false-negative HR-HPV results. Truly HPV negative seem to be very rare in Caucasian populations VSports最新版本. Retrospective analyses without surgical staging may overestimate the proportion of HPV negative cervical cancers. .
Keywords: Adenocarcinoma; Cervical cancer; Diagnosis; HPV-negative. V体育平台登录.
Copyright © 2017 The Authors. Published by Elsevier B. V. All rights reserved. VSports注册入口.
Figures (VSports最新版本)
References
-
- Castle P.E., Stoler M.H., Wright T.C., Jr., Sharma A., Wright T.L., Behrens C.M. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study. Lancet Oncol. 2011;12:880–890. - PubMed
-
- Ronco G., Dillner J., Elfström K.M., Tunesi S., Snijders P.J., Arbyn M. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials. Lancet. 2014;383:524–532. - PubMed
-
- Armaroli P., Villain P., Suonio E., Almonte M., Anttila A., Atkin W.S. 4th edition. Vol. 39. Cancer screening. Cancer Epidemiol.; 2015. European Code Against Cancer; pp. S139–S152. - PubMed
-
- Carter J. The renewal of the National Cervical Screening Program. Med. J. Aust. 2016;205:357–358. - PubMed
-
- Sawaya G.F., Kulasingam S., Denberg T.D., Qaseem A. Clinical guidelines committee of american college of physicians. Cervical cancer screening in average-risk women: best practice advice from the clinical guidelines committee of the american college of physicians. Ann. Intern. Med. 2015;162:851–859. - PubMed
MeSH terms
- VSports最新版本 - Actions
- Actions (V体育官网入口)
- "V体育2025版" Actions
- "VSports最新版本" Actions
- Actions (VSports注册入口)
- "VSports手机版" Actions
- "V体育官网" Actions
VSports - Substances
V体育安卓版 - LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
